Literature DB >> 11015640

Neuroleptic malignant syndrome associated with use of risperidone, ritonavir, and indinavir: a case report.

S I Lee, J Klesmer, B E Hirsch.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11015640     DOI: 10.1176/appi.psy.41.5.453

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


× No keyword cloud information.
  5 in total

Review 1.  Drug interactions between antiretroviral drugs and comedicated agents.

Authors:  Monique M R de Maat; G Corine Ekhart; Alwin D R Huitema; Cornelis H W Koks; Jan W Mulder; Jos H Beijnen
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  Identification of Cytochrome P450-Mediated Drug-Drug Interactions at Risk in Cases of Gene Polymorphisms by Using a Quantitative Prediction Model.

Authors:  Nicolas Fermier; Laurent Bourguignon; Sylvain Goutelle; Nathalie Bleyzac; Michel Tod
Journal:  Clin Pharmacokinet       Date:  2018-12       Impact factor: 6.447

Review 3.  Pharmacologic treatment of mood disorders in acquired immune deficiency syndrome (AIDS).

Authors:  Jordan Klesmer; Ruxandra Badescu
Journal:  Curr Psychiatry Rep       Date:  2002-06       Impact factor: 8.081

4.  Drug-drug interactions between COVID-19 treatments and antipsychotics drugs: integrated evidence from 4 databases and a systematic review.

Authors:  Beatriz Oda Plasencia-García; Gonzalo Rodríguez-Menéndez; María Isabel Rico-Rangel; Ana Rubio-García; Jaime Torelló-Iserte; Benedicto Crespo-Facorro
Journal:  Psychopharmacology (Berl)       Date:  2021-01-07       Impact factor: 4.530

Review 5.  Clinically Significant Drug Interactions Between Psychotropic Agents and Repurposed COVID-19 Therapies.

Authors:  Milo Gatti; Fabrizio De Ponti; Federico Pea
Journal:  CNS Drugs       Date:  2021-04-18       Impact factor: 5.749

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.